Review Note
Last Update: 10/06/2024 07:14 PM
Current Deck: Geneeskunde::3e bachelor::long & hart::ZSO 7 farmacologie hartfalen
Published
Fields:
Front
Digoxine- indicatie? en therapeuthische window?
Back
- Indicated for chronic HFrEF in sinus rhythm as ‘safe’ mild inotropic agent
- Used mostly in Afib to slow down AV conduction (takes hours)
- Very narrow therapeutic window 0.5-1 (higher = toxicity)
- Digoxin has a class IIb recommendation to reduce HFH in HFrEF
Suggested Changes:
Deck Changes (Suggestion to move the Note to the following Deck):
Field Changes:
Tag Changes: